Zacks Investment Research on MSN
BAYRY reports positive data on kidney drug in non-diabetic CKD
Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone ...
In an editorial, one expert said the choice of DOAC in VTE is “no longer a toss-up,” with apixaban the clear winner.
The Inflation Reduction Act (IRA) has reshaped how Medicare covers and reimburses prescription drugs. For the first time, the federal ...
Spread the lovePublic Perception of Drug Costs Recent polling data indicates a significant shift in the American public’s perception of drug pricing, attributing the decline in costs to former ...
Reining in drug prices has been a priority for both the Trump and Biden administrations, but Trump is getting more credit for ...
A trial directly comparing two commonly used blood-thinning drugs found that one carries a lower risk of dangerous bleeding ...
March 13 () - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same class of medicines - found that Eliquis carries a clearly lower risk of dangerous ...
A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same class of medicines - ...
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...
On February 5, 2026, President Trump released another namesake initiative, this time aimed at prescription drug prices. The ...
The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and ...
BAYRY posts in-line Q4 earnings but revenues miss on lower Xarelto and Eylea sales. 2026 sales guidance signals steady growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results